POP inhibitors (Chinoin)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePOP inhibitors (Chinoin)
Drug Alias Nameprolyl oligopeptidase inhibitors (Chinoin)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProlyl endopeptidase inhibitors
TargetsProlyl endopeptidase
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChinoin Pharmaceutical And Chemical Works Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChinoin Pharmaceutical And Chemical Works Co Ltd
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A